These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 30286779

  • 1. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.
    Zuo D, Shogren KL, Zang J, Jewison DE, Waletzki BE, Miller AL, Okuno SH, Cai Z, Yaszemski MJ, Maran A.
    J Exp Clin Cancer Res; 2018 Oct 04; 37(1):244. PubMed ID: 30286779
    [Abstract] [Full Text] [Related]

  • 2. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT, Tang F, Hu X, Zheng CX, Gong TJ, Zhou Y, Luo Y, Min L.
    IUBMB Life; 2020 Oct 04; 72(10):2146-2153. PubMed ID: 33448097
    [Abstract] [Full Text] [Related]

  • 3. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C, Zhang H, Yu Y, Huang Q, Wang W, Niu J, Lou J, Ren T, Huang Y, Guo W.
    Aging (Albany NY); 2021 Jun 24; 13(13):17901-17913. PubMed ID: 34170850
    [Abstract] [Full Text] [Related]

  • 4. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR, Yun HM, Quang TH, Oh H, Lee DS, Auh QS, Kim EC.
    Oncotarget; 2016 Feb 09; 7(6):6960-71. PubMed ID: 26755649
    [Abstract] [Full Text] [Related]

  • 5. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B, Ren T, Huang Y, Guo W.
    Biochem Biophys Res Commun; 2018 Jan 08; 495(2):1695-1701. PubMed ID: 29225166
    [Abstract] [Full Text] [Related]

  • 6. Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
    Ji XL, He M.
    Aging (Albany NY); 2019 Aug 15; 11(15):5848-5863. PubMed ID: 31422383
    [Abstract] [Full Text] [Related]

  • 7. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M, Zhang T, Wang Z, Wang H, Xu J, Yin F, Wang G, Sun M, Wang Z, Hua Y, Cai Z.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1214-1225. PubMed ID: 30659925
    [Abstract] [Full Text] [Related]

  • 8. Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.
    Zhang T, Li J, Yin F, Lin B, Wang Z, Xu J, Wang H, Zuo D, Wang G, Hua Y, Cai Z.
    Oncogene; 2017 Nov 23; 36(47):6627-6639. PubMed ID: 28783167
    [Abstract] [Full Text] [Related]

  • 9. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B, Zhu J, Liu S, Wang L, Fan Q, Hao Y, Fan C, Tang TT.
    Oncotarget; 2016 Jul 26; 7(30):48296-48308. PubMed ID: 27340780
    [Abstract] [Full Text] [Related]

  • 10. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T, Asanuma K, Matsumine A, Matsubara T, Nakamura T, Iino T, Asanuma Y, Goto M, Okuno K, Kakimoto T, Yada Y, Sudo A.
    Int J Oncol; 2016 Dec 26; 49(6):2275-2284. PubMed ID: 27840900
    [Abstract] [Full Text] [Related]

  • 11. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J, Zhang W, Di T, Meng J, Qi Y, Li G, Zhang Y, Su H, Yan W.
    Biomed Pharmacother; 2020 Nov 26; 131():110541. PubMed ID: 33152901
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo.
    Thulin MH, Määttä J, Linder A, Sterbova S, Ohlsson C, Damber JE, Widmark A, Persson E.
    Prostate; 2021 Jun 26; 81(8):452-462. PubMed ID: 33822400
    [Abstract] [Full Text] [Related]

  • 13. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI, Liu A, Lin L, Wei CC, Schwartz EB, Bhasin D, Li C, Fuchs JR, Li PK, Houghton P, Termuhlen A, Gross T, Lin J.
    Invest New Drugs; 2012 Jun 26; 30(3):916-26. PubMed ID: 21340507
    [Abstract] [Full Text] [Related]

  • 14. Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
    Wang X, Goldstein D, Crowe PJ, Yang JL.
    Anticancer Res; 2014 Nov 26; 34(11):6537-45. PubMed ID: 25368256
    [Abstract] [Full Text] [Related]

  • 15. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
    Wang L, Xue GB.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):27-34. PubMed ID: 29032182
    [Abstract] [Full Text] [Related]

  • 16. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B, Du L, Fan QM, Tang Z, Tang TT.
    Cancer Lett; 2012 Dec 01; 325(1):80-8. PubMed ID: 22743617
    [Abstract] [Full Text] [Related]

  • 17. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C, Ma K, Li WY.
    Drug Des Devel Ther; 2019 Dec 01; 13():4075-4090. PubMed ID: 31824138
    [Abstract] [Full Text] [Related]

  • 18. Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
    Wang S, Wang Y, Huang Z, Wei H, Wang X, Shen R, Lan W, Zhong G, Lin J.
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec 08; 53(12):1670-1680. PubMed ID: 34693451
    [Abstract] [Full Text] [Related]

  • 19. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J, Ma Y, Wang G, Han X, Zhang C.
    DNA Cell Biol; 2013 Apr 08; 32(4):156-64. PubMed ID: 23451817
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma.
    Wang Z, Shen J, Sun W, Zhang T, Zuo D, Wang H, Wang G, Xu J, Yin F, Mao M, Zhou Z, Hua Y, Cai Z.
    Cancer Sci; 2019 May 08; 110(5):1746-1759. PubMed ID: 30907478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.